Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.
about
Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery.Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational researchPerspectives for therapeutic HPV vaccine developmentDNA vaccine for cancer immunotherapyStrategies for improving responses to DNA vaccinesImmunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigenDNA vaccines: developing new strategies against cancer.DNA and RNA-based vaccines: principles, progress and prospects.Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.DNA vaccines against human immunodeficiency virus type 1 in the past decade.Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.Distinct temporal programming of naive CD4+ T cells for cell division versus TCR-dependent death susceptibility by antigen-presenting macrophagesA multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine modelDNA vaccines, electroporation and their applications in cancer treatmentBone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation.Trial watch: Dendritic cell-based interventions for cancer therapyRoute and method of delivery of DNA vaccine influence immune responses in mice and non-human primatesGeneration of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvantDNA vaccines: influenza virus challenge of a Th2/Tc2 immune response results in a Th2/Tc1 response in the lung.Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccinesCurrent state in the development of candidate therapeutic HPV vaccinesThe current state of therapeutic and T cell-based vaccines against human papillomaviruses.Induction of antiviral antibodies by DNA immunization requires neither perforin-mediated nor CD8(+)-T-cell-mediated lysis of antigen-expressing cells.Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drugRecruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.
P2860
Q25257540-A0619EE6-360A-4AFB-8F9E-DCBCB1BEFDC8Q26744094-92E1AB1A-AC2E-4298-8F1D-502EA63F71C2Q28069272-69B7BA98-F9F0-41E1-BEE7-96FDE4257740Q28080919-5EAF6EA7-5364-437E-BA49-BF0D3F1FE756Q33540135-E1EC5D38-CB2B-4999-B7B3-814A73878D11Q33576984-B5B24B03-EA10-4583-8F81-D5685266F26BQ33670432-A95F8224-4872-4D1F-9737-4284850FC116Q33756622-EB358609-72F9-446F-A3F3-CB56BE0C606FQ33783789-BC4E3D7F-F459-48EE-A418-7575BD5A4D1FQ33806715-63811C54-B790-4580-AABB-3148E6BC30BAQ33844695-160C620A-12AA-4ECC-8A5C-2027C8949A2CQ33845229-B295C5B3-82A9-4A56-8BAF-0418D552EBEFQ35745831-5B610BC9-A270-4A86-97E6-26B73271E1D7Q35750908-921A8B15-0F4B-493A-A0EA-5AC93B3D0EC0Q35793125-694B4642-AF39-4DB2-B713-B6BCBF83DFBFQ36037271-53AC8AF3-BDB9-4616-BA50-568D3DEA4780Q36256459-A1254585-5D03-4DDD-916A-9B0EEDD51E87Q36376037-0F7C7740-58B2-4D58-BA12-E074F4FCCCB0Q36388529-FA5A8FE2-3D4E-4405-8563-96FF05126134Q36438450-24BCD3FF-9396-46CE-AA8E-CC4AE7400898Q36694830-3652B8CB-4CBC-4EFE-BFBD-2BB6CA7CA1A7Q37094074-C5BE8E42-9598-43E0-B054-9D15A0D2BC28Q37276912-1996DAED-2B4F-40FF-BC6C-FE43F05B938EQ37708724-33EBDD92-ABC6-4BAC-BA1F-9A35345F4F0BQ38743922-EBD26ACD-AD45-4C72-AEA8-756D49E02E4DQ39033576-67720B2D-3FF4-441F-96D3-E106D228E929Q39551181-3A57D557-93CE-4289-89B7-C1032F4C6476Q39672052-A03EA19C-BAA1-497F-994C-836D4B761835Q40247465-920FF4C4-CED4-4DA5-A282-ACF545D65189Q42181972-2D8233DF-A924-40A5-9FE9-312AC5351B78Q43482777-628E9CE3-2985-440D-9A26-2590C5F93B07
P2860
Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Specific immune induction foll ...... ages/antigen-presenting cells.
@ast
Specific immune induction foll ...... ages/antigen-presenting cells.
@en
Specific immune induction foll ...... ages/antigen-presenting cells.
@nl
type
label
Specific immune induction foll ...... ages/antigen-presenting cells.
@ast
Specific immune induction foll ...... ages/antigen-presenting cells.
@en
Specific immune induction foll ...... ages/antigen-presenting cells.
@nl
prefLabel
Specific immune induction foll ...... ages/antigen-presenting cells.
@ast
Specific immune induction foll ...... ages/antigen-presenting cells.
@en
Specific immune induction foll ...... ages/antigen-presenting cells.
@nl
P2093
P1476
Specific immune induction foll ...... hages/antigen-presenting cells
@en
P2093
Chattergoon MA
Robinson TM
P304
P407
P577
1998-06-01T00:00:00Z